Gut bacteria treatment for fatty liver disease
Part of Digestive system, Hormones & metabolism clinical trials.
This study tests whether a specially designed gut bacteria treatment can help people with fatty liver disease and related health issues like high blood sugar, high cholesterol, or high blood pressure. It aims to see if the treatment is safe and improves liver health.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 20 and 70 years old.
- You have fatty liver disease, confirmed by a FibroScan test, and at least one of these: a body mass index (BMI) of 23 or higher, a large waist size, high blood sugar or diabetes, high blood pressure, high triglycerides, or low 'good' cholesterol.
- You have not taken probiotics, prebiotics, antibiotics, or certain anti-inflammatory drugs recently (within 14 to 30 days).
- You are not pregnant, breastfeeding, or planning to travel outside the country for an extended period during the study.
- You are willing to provide stool samples and follow all study procedures for about 6 months.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a specific medical nutrition therapy diet to see if it can reduce liver fat and improve blood sugar control in people with type 2 diabetes and nonalcoholic fatty liver disease. It may help you manage both conditions with a dietary approach.
This trial tests if rifaximin, a gut medication, can help reduce liver fat in people with metabolic fatty liver disease. It may be an option if you have at least one metabolic risk factor and a certain amount of liver fat.
This trial tests whether taking probiotics plus making lifestyle changes can improve fatty liver and metabolic health. You may qualify if you have liver fat and at least one sign of metabolic problems like high blood sugar or high blood pressure.
This trial tests whether a special mix of probiotics can help improve liver health in people with fatty liver disease related to metabolism. It measures changes in liver enzymes, fat, and stiffness over time.
This trial tests whether a probiotic mixture can improve liver health in people with moderate fatty liver disease (MASLD). It looks at how the probiotic affects liver fat, inflammation, and metabolism.
This study tests whether probiotics and a specific exercise program can help people with fatty liver disease, including the inflammatory type. It aims to see if these treatments can improve liver health.
Hear when a new Metabolic Dysfunction-Associated Steatotic Liver Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.